Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | AEP-IN-3 (compound 18) is an orally administered, potent asparagine endopeptidase (AEP) inhibitor that effectively crosses the blood-brain barrier. It boasts an IC50 of 7.8 ± 0.9 nM and is applicable in Alzheimer’s Disease (AD) research [1]. |
In vivo | AEP-IN-3 (Compound 18) exhibits a bioavailability of 83% with a half-life of T 1/2 [1]. Administered orally at a dosage of 20 mg/kg twice daily with a 7-8 hour interval for five consecutive days, AEP-IN-3 showed significant inhibition of AEP activity in the brains of transgenic mice carrying human Tau 2N4R isoform with P301L mutation in the FVB/N genetic background (3.8 months old) [1]. It also reduced the formation of Tau N368 fragments, although it did not significantly affect total Tau levels [1]. |
Molecular Weight | 455.4 |
Formula | C21H21F4N3O4 |
Cas No. | 2978521-26-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.